Mirati Therapeutics, Inc. announced that Marcy Graham has been appointed Vice President, Investor Relations (IR) and Corporate Communications. As a seasoned communicator, Ms. Graham has more than 15 years of experience in the biopharmaceutical sector with expertise in growth companies and related transitions, such as the management of IPOs, financings and M&A activities, commercial product launches, and clinical development programs. Before joining Mirati, Ms. Graham was Vice President, Investor Relations and Corporate Communications at aTyr Pharma, participating in two major financings including their IPO in 2015.